Blueprint library/Reg

Regulatory Change Impact & Commitment Management Software

A quality change is not complete until every affected market can use it.

Connect QMS changes, health-authority commitments, market assessments, submission dependencies, implementation controls, and closure evidence without turning the QMS into a second RIMS.

The change was approved. The product still could not ship.

A manufacturing-site change passed technical review, validation, quality approval, and local implementation. The change record was green. Months later, supply planning learned that several markets required regulatory action before product made at the new site could be distributed there.

Nothing was wrong with the engineering package. The failure sat between systems: change control knew what changed; regulatory affairs knew the registrations; neither record governed when each market could use the changed state.

Regulatory Lifecycle
Fig. 1 / Regulatory Lifecycle
01

The blueprint governs the QMS-to-regulatory seam

This is not a second RIMS and it is not an eCTD publisher. RIMS remains the authoritative portfolio of products, registrations, dossiers, submissions, correspondence, and approved market states. Submission management plans and dispatches filing packages. Change control governs the proposed operational change.

This blueprint joins them. It determines which registered products and markets may be affected, records the accountable regulatory assessment, creates the required regulatory actions, blocks implementation where approval is a prerequisite, and returns evidence to the quality record.

That boundary makes the workflow useful: one global change, many market decisions, explicit release conditions.

02

Start with a precise change scope

Regulatory assessment cannot recover from a vague source record. The change carries the before and proposed-after state for product, material, specification, process, method, equipment, software, site, supplier, packaging, labeling, storage, shelf life, or control strategy.

Reason, urgency, affected facilities, planned effective date, validation strategy, inventory exposure, and temporary-versus-permanent status are structured. Supporting documents remain linked to the claims they establish.

03

Derive the affected product-market set

The system traverses governed relationships from the changed object to products, presentations, registrations, manufacturing and testing sites, dossiers, labels, and commitments. It produces a candidate impact set with the relationship that caused each market to appear.

Regulatory owners confirm, add, or exclude candidates with rationale. Automation proposes scope; an accountable person owns it. A market is never silently removed because a reference was incomplete.

Regulatory Commitments
Fig. 2 / Regulatory Commitments
04

Assess each market against an effective requirement

For every affected registration, regulatory affairs records classification, legal or procedural basis, required data, submission type, authority interaction, approval-before-implementation rule, reporting window, grouping opportunity, local document need, fee, expected review path, and uncertainty.

Requirements are versioned by jurisdiction, product class, procedure, and effective date. A rule update creates a review task for open assessments; it does not rewrite the historical basis of a signed decision.

05

Preserve alternatives and regulatory judgment

The system does not pretend that every classification is deterministic. Precedent, authority advice, product knowledge, regional interpretation, and risk can produce alternatives.

Each assessment retains the options considered, evidence, assumptions, dissent, consultation, chosen strategy, approver, and date. A later reviewer can understand why a market was classified—not merely see the final dropdown value.

06

Convert assessments into an executable plan

Required actions become owned work: data generation, document authoring, translation, local affiliate review, publishing, dispatch, fee payment, authority response, approval, notification, label implementation, and commitment fulfillment.

Dependencies form a real network. A filing cannot be ready before its evidence; an implementation gate cannot open before the required approval; a market launch cannot precede the approved state. Forecast dates may move without changing statutory dates.

07

Make implementation conditional by market

There is rarely one global effective date. Some markets may permit implementation before notification, others after a defined waiting period, and others only after approval. Existing inventory, product manufactured under the previous state, packaging, and release status can add further constraints.

Seal maintains a market implementation matrix: proposed, allowed, blocked, approved, implemented, and verified. MES, ERP, labeling, release, and distribution controls can consume the applicable decision rather than infer it from a closed change record.

08

Control split-state operations deliberately

During a transition, both old and new states may be legitimate. A batch can be suitable for one market and ineligible for another. The record therefore connects material and batch genealogy, manufacture date, packaging version, destination market, registration state, and implementation authorization.

Exceptions require a documented decision and approval. Teams can see where dual-state operation exists, how long it is planned to last, and what must happen before convergence.

09

Treat authority correspondence as decision evidence

Meeting minutes, questions, information requests, deficiency letters, advice, approvals, acknowledgements, and commitments link to the market assessment and topic they affect.

A question about comparability can change the evidence plan. An approval condition can become a new commitment. The correspondence is not an attachment graveyard; it is evidence that changes the executable regulatory position.

10

Health-authority commitments become controlled obligations

Commitments can originate in approval letters, inspection responses, meeting minutes, submissions, variations, safety measures, or formal correspondence. Each obligation records the exact source text, interpretation, jurisdiction, product, deliverable, milestone, dependency, owner, escalation, evidence requirement, submission link, and acceptance state.

Completion means the promised outcome and evidence exist. Dispatch may satisfy a filing milestone but does not automatically prove that an authority has accepted or closed the obligation.

11

Dates keep their distinct meanings

Awareness date, statutory due date, internal target, forecast completion, filing date, authority receipt, validation acknowledgement, review clock start, clock stop, response due date, approval date, implementation date, and commitment closure are separate fields.

The plan can forecast risk without moving the legal deadline. Calendar calculations retain the rule and calendar used so that the result is explainable.

12

Escalation follows consequence, not a generic reminder cadence

An approaching internal target and an approaching legal due date are not equivalent. Escalations consider remaining work, critical-path dependencies, approval prerequisites, market supply impact, owner response, and current forecast.

Leadership sees obligations at risk with causes and recovery actions. Notifications are an output of the controlled plan, not the plan itself.

13

Evidence remains attributable and source-bound

AI may extract candidate obligations, dates, products, and deliverables from controlled correspondence. It may compare proposed wording with approved positions or identify registrations connected to a changed site. Every suggestion retains its source passage, confidence, model and prompt version, reviewer decision, and correction.

It cannot approve a classification, invent a requirement, close a commitment, or authorize implementation. Those actions remain signed decisions by designated roles.

14

Changes can be bundled without losing traceability

One submission may address several changes, and one change may require many submissions. The many-to-many relationship remains explicit down to the affected dossier content and approved outcome.

Bundling decisions retain rationale and dependency. If one element is withdrawn or questioned, teams can determine which changes and markets are affected without reconstructing the package from filenames.

15

Closure reconciles quality and regulatory truth

The global change closes only under an approved closure policy: all required assessments completed, actions dispositioned, prerequisite approvals received, permitted implementation executed, evidence linked, residual exceptions accepted, commitments created, and downstream master data synchronized.

Markets intentionally deferred remain visible with owners and conditions. “Closed” never means the remaining work disappeared into another department.

16

Portfolio views answer operational questions

Which approved changes are waiting on regulatory action? Which markets block use of the new site? Which commitments are due this quarter? Which submissions contain evidence from Change CC-0148? Which registrations still use the previous specification? Which market assessments lack a current rule basis?

Every aggregate drills into the source change, assessment, requirement, action, submission, authority outcome, and signed decision.

17

The audit record reconstructs the entire handoff

For any change, Seal can show its original scope, affected-product derivation, market assessments, reviewers, requirement versions, planned actions, correspondence, submissions, approvals, implementation gates, exceptions, evidence, commitments, and final reconciliation.

That is the defensible record: not that two systems both said “complete,” but that every affected market moved from one controlled state to another under an accountable decision.

Operating model

Native control model
States and decisions owned by this blueprint
08 native controls
Affected-Market Derivation
Trace a quality change through products, sites, registrations, dossiers, labels, and commitments to produce a reviewable regulatory impact set.
Market-Specific Assessment
Record classification, basis, alternatives, required evidence, filing path, timing, uncertainty, and accountable approval for each affected registration.
Implementation Gates
Keep market use blocked until required notification, waiting period, or approval conditions are met and verified.
Commitment Management
Turn exact authority promises and approval conditions into owned, evidence-backed obligations with meaningful milestones and closure criteria.
Submission Traceability
Connect many changes to many submissions without losing the dossier content, authority outcome, or market state each filing affects.
Split-State Control
Govern old and new product states by batch, inventory, label, destination market, and effective authorization during a transition.
Source-Bound Extraction
Extract candidate obligations and affected objects from controlled sources while preserving citations, reviewer decisions, and model provenance.
Closure Reconciliation
Close the quality-to-regulatory handoff only after assessments, actions, approvals, implementation, exceptions, commitments, and master data reconcile.
Regulatory Change Impact & Commitment Management Software owns the operating state above; connected foundations remain authoritative for their specialized records.

Capabilities

01native controlAffected-Market Derivation
Trace a quality change through products, sites, registrations, dossiers, labels, and commitments to produce a reviewable regulatory impact set.
02native controlMarket-Specific Assessment
Record classification, basis, alternatives, required evidence, filing path, timing, uncertainty, and accountable approval for each affected registration.
03native controlImplementation Gates
Keep market use blocked until required notification, waiting period, or approval conditions are met and verified.
04native controlCommitment Management
Turn exact authority promises and approval conditions into owned, evidence-backed obligations with meaningful milestones and closure criteria.
05native controlSubmission Traceability
Connect many changes to many submissions without losing the dossier content, authority outcome, or market state each filing affects.
06native controlSplit-State Control
Govern old and new product states by batch, inventory, label, destination market, and effective authorization during a transition.
07native controlSource-Bound Extraction
Extract candidate obligations and affected objects from controlled sources while preserving citations, reviewer decisions, and model provenance.
08native controlClosure Reconciliation
Close the quality-to-regulatory handoff only after assessments, actions, approvals, implementation, exceptions, commitments, and master data reconcile.

Entities

Entity
Description
Kind
C
Quality Change
Controlled before-and-after operational change with reason, scope, evidence, validation, target dates, and approval state.
type
C
Manufacturing Site Change
Site addition, transfer, removal, or responsibility change with validation, supply, registration, and market-use impacts.
template
C
CC-0148 / Site Addition
New drug-product manufacturing site assessed against 42 active registrations and three planned launches.
instance
C
Specification Change
Acceptance-criterion, test, method, or control-strategy change assessed across registered product states.
template
DT
Regulatory Impact Set
Candidate products, presentations, registrations, markets, sites, dossiers, labels, and commitments affected by a source change.
type
G
Market Assessment
Market-specific classification, basis, alternatives, evidence need, filing path, timing, implementation constraint, uncertainty, and approval.
type
G
Post-Approval Change Assessment
Jurisdiction-specific classification and evidence decision for a proposed CMC or quality change.
template
G
REG-ASMT-EU-0148
EU assessment records classification, evidence, grouping, approval dependency, strategy approval, and effective rule version.
instance
P
Regulatory Requirement
Versioned jurisdiction, product, procedure, timing, content, format, and approval-before-implementation rule.
type
LD
Regulatory Action
Owned evidence, authoring, review, translation, publishing, dispatch, response, approval, or implementation work.
type
PS
Market Implementation
Authorization and actual effective state for a product-market, including inventory, batch, label, and distribution constraints.
type
PS
Prior-Approval Gate
Market remains blocked until the required health-authority approval is effective and verified.
template
PS
MKT-GATE-JP-0148
Japan-bound batches made at the new site remain ineligible until the linked approval is confirmed.
instance
SM
Submission Link
Many-to-many link between changes, market assessments, dossier content, filing sequences, and authority outcomes.
type
C
Authority Correspondence
Question, response, advice, acknowledgement, approval, condition, or meeting record and the decision it changes.
type
E
Regulatory Commitment
Source-bound obligation with interpretation, deliverable, milestone, owner, evidence, escalation, filing, acceptance, and closure.
type
E
Inspection Response Commitment
Source-bound promise from an inspection response with deliverables, milestones, evidence, and closure criteria.
template
E
REG-COMMIT-0082
Revised cleaning-validation protocol commitment retains source statement, owner, milestones, submission evidence, and authority status.
instance
E
Approval Condition
Study, validation, stability, labeling, safety, reporting, or other condition attached to an approval.
template
WS
Regulatory Exception
Approved deferral, exclusion, temporary control, unresolved uncertainty, or departure from the global implementation plan.
type

FAQ

RIMS is the authoritative regulatory portfolio: products, registrations, dossiers, submissions, correspondence, and approved states. This blueprint governs the handoff from a QMS change or commitment into market-specific assessment, action, implementation gating, and evidence-backed closure. It uses RIMS data rather than duplicating it.
No. Rules and connected data can propose affected markets and candidate paths. A qualified regulatory owner reviews the effective requirement, evidence, precedent, alternatives, and uncertainty, then signs the assessment.
Yes. Changes and submissions are many-to-many. Each link retains the affected market, dossier content, assessment, approval outcome, and implementation consequence so bundling does not erase traceability.
Only if the approved closure policy permits it. Deferred markets remain explicit exceptions with owners, controls, dates, and conditions. The record cannot imply that unresolved regulatory work disappeared.
The market implementation record stays blocked until the linked authority outcome is effective and verified. Release, labeling, inventory, or distribution workflows can consume that gate for the intended destination.
The promised deliverable and its required evidence must be complete, and any required filing or authority acceptance must have the correct status. Sending a document is not automatically the same as fulfilling the obligation.
It can propose an obligation, source wording, dates, products, and deliverables with a citation and provenance. A designated reviewer must confirm the interpretation, ownership, milestones, and closure criteria; AI cannot close or approve the commitment.
Statutory due dates, internal targets, forecasts, filings, authority acknowledgements, clock stops, responses, approvals, implementation, and closure remain separate. A slipping forecast never silently moves a legal deadline.
The system records which batches, inventory, labels, and markets may use each state. Exceptions are approved and time-bound, and the transition remains visible until all intended markets converge or are formally dispositioned.
No. It gives global and local teams a shared evidence model, routes ownership, and makes decisions visible. Regional expertise, authority interaction, and accountable approval remain essential.

Related blueprints

RecallProduct Recall & Market Action Management Software

Recalls and market actions. Find the exact population, reach every consignee, prove effectiveness.

Run health-hazard evaluation, affected-lot and unit scope, recall strategy, authority communication, consignee notification, response tracking, product reconciliation, effectiveness checks, status reporting, and termination.

PACMPPost-Approval CMC Change & PACMP Management Software

One technical change. Every market pathway, commitment, and implementation condition resolved.

Assess post-approval CMC changes across products and markets, govern established conditions and PACMPs, assemble comparability evidence, track authority outcomes, and prevent premature implementation.

Supplier ChangePharmaceutical Supplier Change Notification Management Software

One external change. Every material, process, batch, study, filing, and market consequence resolved before use.

Receive supplier change notifications, establish affected supplied items and lots, calculate where-used impact, plan evidence, respond to the supplier, govern inventory transition, and authorize implementation by product and market.

Compendial ChangePharmacopoeial & Compendial Change Management Software

Publication change to affected monograph. Monograph to every material, method, specification, product, filing, and implementation deadline.

Monitor USP, Ph. Eur., JP and other compendial changes, compare requirements, calculate product and market impact, evaluate methods and specifications, plan laboratory and regulatory evidence, govern dual-state implementation, and prove timely compliance.

Partner QualityPharmaceutical Quality Agreements & External Partner Governance Software

Quality agreements. Turn written responsibilities into routed work, evidence, and accountable decisions.

Make sponsor, CDMO, laboratory, supplier, packaging, storage, and distribution responsibilities executable across notifications, investigations, record exchange, release, escalation, performance, and review.

PAT / RTRTPharmaceutical PAT & Real-Time Release Testing Software

Process signal to quality prediction. Prediction to an authorized release decision.

Govern PAT methods, sensors, chemometric models, calibration sets, predictions, process actions, model lifecycle, RTRT strategies, fallback testing, and batch-release evidence.

Go live in 48 hours.